Dr. Butler answers why he is not confident that costs will ever be controlled.
Stuart Butler, PhD, Distinguished Fellow and Director, Center for Policy Innovation, The Heritage Foundation, states that the cost curve will never go down on the track we are currently on. Dr. Butler addresses the need for new approaches to bending the curve.
How Health Systems, Pharmacy Teams Tackle Rare Disease Therapy Barriers: David Mitchell, PharmD, MBA
September 24th 2025David Mitchell, PharmD, MBA, senior pharmacist manager and assistant clinical professor at UC Davis, addresses how health systems are overcoming financial, operational, and access challenges for patients with rare diseases.
Read More